1
WGA in Platinum-refractory HNSCC Underwent Nivolumab
Condition(s):HNSCCLast Updated:April 25, 2019Recruiting
Nivolumab Injection: 1324 Clinical Trials, Page 1 of 133
Hide Studies Not Open or Pending
2
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation
Condition(s):Hepatocellular CarcinomaLast Updated:July 9, 2020Recruiting
3
Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.
Condition(s):Metastatic Pancreatic CancerLast Updated:November 2, 2020Recruiting
4
Nivolumab in Recurrent and/or Metastatic SCCHN
Condition(s):Recurrent and/or Metastatic Platinum-refractory SCCHNLast Updated:November 20, 2020Active, not recruiting
5
Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction
Condition(s):Oral Cavity Squamous Cell CarcinomaLast Updated:October 8, 2020Recruiting
6
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
Condition(s):Hematologic MalignanciesLast Updated:June 25, 2020Terminated
7
ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma
Condition(s):Hodgkin LymphomaLast Updated:November 17, 2020Recruiting
8
Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer
Condition(s):Kidney Cancer; Lung CancerLast Updated:November 12, 2019Completed
9
COMbination of Bipolar Androgen Therapy and Nivolumab
Condition(s):Castration-resistant Prostate Cancer; Metastatic Prostate Cancer; Prostate CancerLast Updated:November 3, 2020Active, not recruiting
10
Neoadjuvant Nivolumab in Glioblastoma
Condition(s):Glioblastoma MultiformeLast Updated:April 11, 2017Completed